Effect of 1‐ and 2‐Month High‐Dose Alpha‐Linolenic Acid Treatment on 13C‐Labeled Alpha‐Linolenic Acid Incorporation and Conversion in Healthy Subjects
Scope The study aims at identifying 1) the most sensitive compartment among plasma phospholipids, erythrocytes, and LDL for studying alpha‐linolenic acid (ALA) conversion, and 2) whether ALA incorporation and conversion is saturable after administration of 13C‐labeled ALA‐rich linseed oil (LO). The...
Saved in:
Published in | Molecular nutrition & food research Vol. 62; no. 20 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc
01.10.2018
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Scope
The study aims at identifying 1) the most sensitive compartment among plasma phospholipids, erythrocytes, and LDL for studying alpha‐linolenic acid (ALA) conversion, and 2) whether ALA incorporation and conversion is saturable after administration of 13C‐labeled ALA‐rich linseed oil (LO). The effect of a daily intake of 7 g nonlabeled LO (>43% w/w ALA) for 1 month after bolus administration of 7 g 13C‐labeled LO on day 1, and for 2 months after bolus administration of 7 g 13C‐labeled LO on day 1 and day 29 on 13C‐ALA incorporation and conversion into its higher homologs is investigated in healthy volunteers.
Methods and results
Incorporation and conversion of LO‐derived 13C‐labeled ALA is quantified by applying compartmental modeling. After bolus administration, a fractional conversion of approximately 30% from 13C‐ALA to 13C‐DHA is calculated as reflected by the LDL compartment. Treatment with LO for 8 weeks induces a mean reduction of 13C‐ALA conversion to 13C‐DHA by 48% as reflected by the LDL compartment, and a mean reduction of the 13C‐ALA incorporation into LDL by 46%.
Conclusion
A 2‐month dietary intake of a high dose of LO is sufficient to reach saturation of ALA incorporation into LDL particles, which are responsible for ALA distribution in the body.
13C‐labeled linseed oil (LO) is used to study the incorporation and conversion of alpha‐linolenic acid in healthy subjects. LDL is identified as the most sensitive compartment compared to plasma phospholipids and erythrocytes to study alpha‐linolenic acid conversion to docosahexaenoic acid. Compartmental modeling reveals a fractional conversion of 30% from 13C‐alpha‐linolenic acid to 13C‐docosahexaenoic acid. Long‐term intake of LO markedly reduces the incorporation of 13C‐alpha‐linolenic acid by 46% and its conversion to 13C‐docosahexaenoic acid by 48%. |
---|---|
Bibliography: | The copyright line for this article was changed on 11 July 2019 after original online publication. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 1613-4125 1613-4133 |
DOI: | 10.1002/mnfr.201800271 |